Financial Analysis
Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data
Filing evidence summary
Mixed evidenceCoverage 5/5 core metricsFlagged areas: Solvency & liquidity, Dilution.
Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.
Evidence signals
- 2 filing risk checks flagged
Flagged areas: Solvency & liquidity, Dilution.
Why this surfaced
The full financial analysis shows each value, threshold, and sector limitation.
- Operating margin was stable
Operating margin changed -0.5 percentage points from the prior annual period.
Why this surfaced
Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.
- Revenue expanded
Latest reported annual revenue changed +9.6% from the prior reported annual observation.
Why this surfaced
Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.
- Free cash flow was positive
Latest reported free cash flow was $497M.
Why this surfaced
Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.
Core trend metrics
Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.
Where to look next
Risk checks
- Solvency & liquidity
- Dilution
Financial movement
- Cash→ flat
- Long-term debt→ flat
- Inventory→ flat
- Receivables→ flat
- Current assets→ flat
Source & freshness
- Source
- SEC EDGAR XBRL
- Fetched
- 2026-09-06
- Latest period end
- 2025-12-31
- Filings
- EDGAR ↗
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product$3.44Bshare n/a+10.0% yoy
- Semiconductor$1.7Bshare n/a+13.2% yoy
- Specialty Industrial$1.12Bshare n/a-3.6% yoy
- Electronics And Packaging$1.11Bshare n/a+20.5% yoy
- Service$495Mshare n/a+7.1% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Other countries$1.03B26.3%+10.6% yoy
- China$931M23.7%+20.1% yoy
- United States$760M19.3%-5.5% yoy
- South Korea$440M11.2%+22.9% yoy
- Singapore$265M6.7%+15.7% yoy
- Taiwan$260M6.6%+11.1% yoy
- Japan$240M6.1%-4.0% yoy
Members sum to the consolidated $3.93B for this period.
- Product$954Mshare n/a+16.5% yoy
- Semiconductor$466Mshare n/a+12.8% yoy
- Electronics And Packaging$321Mshare n/a+26.9% yoy
- Specialty Industrial$291Mshare n/a+7.8% yoy
- Service$124Mshare n/a+6.0% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
Peer percentiles
latest fiscal year ending 2025-12-31 · among 4,003 US-listed filers · 318 in Healthcare| Metric | Value | vs all filers | vs sector |
|---|---|---|---|
Revenue latest fiscal-year revenue as filed | $3.9B | 77thof 3,301 top third | 83rdof 291 top third |
Gross margin gross profit ÷ revenue | 46.7% | 62ndof 1,603 middle third | 35thof 212 middle third |
Operating margin operating income ÷ revenue | 13.4% | 75thof 2,819 top third | 82ndof 280 top third |
Net margin net income ÷ revenue | 7.5% | 65thof 3,263 middle third | 74thof 290 top third |
Free-cash-flow margin (operating cash flow − |capex|) ÷ revenue | 12.6% | 72ndof 2,679 top third | 78thof 261 top third |
Return on equity net income ÷ stockholders' equity (positive equity only) | 10.8% | 69thof 3,576 top third | 77thof 291 top third |
Interest coverage operating income ÷ interest expense (interest expense > 0) | 2.5× | 59thof 819 middle third | 70thof 76 top third |
Stock comp ÷ revenue stock-based compensation ÷ revenue · lower is ranked higher | 1.4% | 59thof 2,895 middle third | 71stof 272 top third |
Days sales outstanding receivables ÷ revenue × 365 · lower is ranked higher | 60 days | 36thof 2,398 middle third | 42ndof 266 middle third |
Net debt ÷ operating cash flow net debt ÷ operating cash flow (OCF > 0) · lower is ranked higher | 5.8× | 22ndof 1,546 bottom third | 20thof 116 bottom third |
Cash conversion operating cash flow ÷ net income (net income > 0) | 2.2× | 68thof 1,684 top third | 71stof 102 top third |
Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.
Earnings quality
latest fiscal year ending 2025-12-31 · accruals and cash conversion as filedPer fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.
Point-in-time ledger
first-reported vs latest filing · periods since 2020-01-01 · 14 changed periods| Line item | Period | First reported | Latest filing | Change | Filings |
|---|---|---|---|---|---|
| Deferred revenue (non-current) ContractWithCustomerLiabilityNoncurrent | balance at 2021-09-30 | $3.5M 10-Q 2021-11-03 | $4M 10-Q 2022-11-07 | +14.3% | first · latest |
| Deferred revenue (non-current) ContractWithCustomerLiabilityNoncurrent | balance at 2021-03-31 | $4.5M 10-Q 2021-05-04 | $5M 10-Q 2022-05-02 | +11.1% | first · latest |
| Deferred revenue (non-current) ContractWithCustomerLiabilityNoncurrent | balance at 2021-01-01 | $5.5M 10-Q 2021-05-04 | $6M 10-K 2023-03-14 | +9.1% | first · latest · 8 filings carry it |
| Deferred revenue (non-current) ContractWithCustomerLiabilityNoncurrent | balance at 2021-12-31 | $2.8M 10-K 2022-02-28 | $3M 10-K 2023-03-14 | +7.1% | first · latest |
| Interest expense InterestExpense | quarter 2021-03-31 | $6.4M 10-Q 2021-05-04 | $6M 10-Q 2022-05-02 | -6.3% | first · latest |
| Interest expense InterestExpense | quarter 2021-06-30 | $6.4M 10-Q 2021-08-05 | $6M 10-Q 2022-08-03 | -6.3% | first · latest |
| Interest expense InterestExpense | quarter 2021-09-30 | $6.3M 10-Q 2021-11-03 | $6M 10-Q 2022-11-07 | -4.8% | first · latest |
| Capital expenditure PaymentsToAcquirePropertyPlantAndEquipment | quarter 2021-03-31 | $26.5M 10-Q 2021-05-04 | $27M 10-Q 2022-05-02 | +1.9% | first · latest |
| Capital expenditure PaymentsToAcquirePropertyPlantAndEquipment | quarter 2021-06-30 | $16.3M 10-Q 2021-08-05 | $16M 10-Q 2022-08-03 | -1.8% | first · latest |
| Stock-based compensation ShareBasedCompensation | fiscal year 2020-12-31 | $29.5M 10-K 2021-02-23 | $30M 10-K 2023-03-14 | +1.7% | first · latest · 3 filings carry it |
| Interest expense InterestExpense | fiscal year 2021-12-31 | $25.4M 10-K 2022-02-28 | $25M 10-K 2024-02-27 | -1.6% | first · latest · 3 filings carry it |
| Deferred revenue (current) ContractWithCustomerLiabilityCurrent | balance at 2021-12-31 | $37.5M 10-K 2022-02-28 | $37M 10-K 2023-03-14 | -1.3% | first · latest · 5 filings carry it |
| Depreciation and amortization DepreciationAndAmortization | quarter 2021-03-31 | $23.8M 10-Q 2021-05-04 | $24M 10-Q 2022-05-02 | +0.8% | first · latest |
| Stock-based compensation ShareBasedCompensation | fiscal year 2021-12-31 | $36.7M 10-K 2022-02-28 | $37M 10-K 2024-02-27 | +0.8% | first · latest · 3 filings carry it |
First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.
Notes by disclosure type
Not available for MKSI yet: no footnote text blocks on file for this filer in the ingested DERA files.
Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.